Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1007 USD
−2.44 M USD
0.00 USD
14.08 M
About Jupiter Neurosciences, Inc.
Sector
Industry
CEO
Christer Rosén
Website
Headquarters
Jupiter
FIGI
BBG0130XFNK0
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of JUNS is 0.6200 USD — it has increased by 3.08% in the past 24 hours. Watch Jupiter Neurosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jupiter Neurosciences, Inc. stocks are traded under the ticker JUNS.
JUNS stock has fallen by −7.33% compared to the previous week, the month change is a −9.85% fall, over the last year Jupiter Neurosciences, Inc. has showed a −84.50% decrease.
We've gathered analysts' opinions on Jupiter Neurosciences, Inc. future price: according to them, JUNS price has a max estimate of 30.00 USD and a min estimate of 30.00 USD. Watch JUNS chart and read a more detailed Jupiter Neurosciences, Inc. stock forecast: see what analysts think of Jupiter Neurosciences, Inc. and suggest that you do with its stocks.
JUNS reached its all-time high on Dec 19, 2024 with the price of 19.5100 USD, and its all-time low was 0.5100 USD and was reached on Apr 11, 2025. View more price dynamics on JUNS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JUNS stock is 12.32% volatile and has beta coefficient of −0.47. Track Jupiter Neurosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Jupiter Neurosciences, Inc. there?
Today Jupiter Neurosciences, Inc. has the market capitalization of 18.84 M, it has increased by 7.34% over the last week.
Yes, you can track Jupiter Neurosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Jupiter Neurosciences, Inc. is going to release the next earnings report on Sep 3, 2025. Keep track of upcoming events with our Earnings Calendar.
JUNS net income for the last quarter is −1.53 M USD, while the quarter before that showed −1.53 M USD of net income which accounts for −0.08% change. Track more Jupiter Neurosciences, Inc. financial stats to get the full picture.
No, JUNS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2025, the company has 4 employees. See our rating of the largest employees — is Jupiter Neurosciences, Inc. on this list?
Like other stocks, JUNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jupiter Neurosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.